Cohort Data From TRANSCEND-CLL-004 of Liso-Cel: William G. Wierda, MD
The associate professor of medicine from MD Anderson Cancer Center discussed data from the phase 1 cohort of liso-cel combined with ibrutinib.
Dr. Wierda on Using CD19-Targeted CAR T Cells in CLL
William G. Wierda, MD, PhD, discusses the use of CD19-targeted CAR T-cell therapy in the treatment of patients with chronic lymphocytic leukemia.
Dr. Wierda Discusses Use of CAR T Cells in CLL
William G. Wierda, MD, PhD, discusses how CAR T cells could become more effective in the treatment of patients with chronic lymphocytic leukemia.